Clinical Trials on Prostate in South Africa
Total 553 results
-
AstraZenecaParexelCompleted
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
Noxopharm LimitedCompletedCancerNew Zealand, Georgia, Australia
-
National Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
Royal North Shore HospitalRecruitingProstate CancerAustralia
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States, Canada
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers Squibb; University of Sydney; Advanced Accelerator Applications; Prostate...Active, not recruitingNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Prostate Cancer | Prostatic DiseaseAustralia
-
Lava TherapeuticsMerck Sharp & Dohme LLCRecruitingMetastatic Castration Resistant Prostate CancerUnited States, Spain, Netherlands
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
Novo Nordisk A/STerminated
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
Prostate Cancer Clinical Trials ConsortiumRecruitingProstate CancerUnited States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
-
Costantine AlbanyHoosier Cancer Research Network; Achieve Life SciencesTerminatedProstate Cancer | PSA | Metastatic Castrate-Resistant Prostate CancerUnited States, Canada
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States, Greece, Switzerland, United Kingdom
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Columbia University; Duke University; Lithuanian University... and other collaboratorsCompletedProstate CancerUnited States, Canada, Lithuania
-
LTN PHARMACEUTICALS, INC.CompletedProstate CancerUnited States
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
US Oncology ResearchPfizerCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | PSA Level Five to Ten | PSA Level Less Than Five | PSA Level Ten to FiftyUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, South Africa
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Progenics Pharmaceuticals, Inc.Completed
-
PRAECIS Pharmaceuticals Inc.CompletedProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Urología Costa RicaCompleted
-
Aptevo TherapeuticsCompletedProstate CancerUnited States, Australia
-
Medical University of South CarolinaNational Cancer Institute (NCI)Active, not recruiting
-
Achieve Life SciencesTeva Pharmaceuticals USATerminatedHormone Refractory Prostate Cancer | Castrate-Resistant Prostate CancerFrance, United States, Spain, United Kingdom, Canada
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate CancerUnited States
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsRecruitingProstate Cancer | Radiotherapy Side EffectDenmark
-
St Vincent's Hospital, SydneyCompleted
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
Inovio PharmaceuticalsCompletedProstate CancerUnited States
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland
-
Central European Cooperative Oncology GroupTerminatedProstate CancerMontenegro, Slovenia, Serbia, Russian Federation, Austria, Poland, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Lithuania, Romania, Slovakia, South Africa
-
VA Office of Research and DevelopmentSanofiCompletedProstate CancerUnited States, Puerto Rico
-
Sumitomo Pharma Switzerland GmbHActive, not recruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States